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a  b  s  t  r  a  c  t
Herbal  medicines  with  anthelmintic  effects  are  alternatives  for the  sustainable  control  and
prevention  of disease  caused  by  gastrointestinal  parasites.  The  nanoencapsulation  of essen-
tial  oils  has  been  proposed  to  enhance  the absorption  of  their  constituents  and  improve
their  efﬁcacy.  The  present  study  aimed  to evaluate  the  efﬁcacy  of  free  and  nanoencapsu-
lated  Eucalyptus  citriodora  essential  oil (EcEO)  on the  control  of  gastrointestinal  nematodes
of small  ruminants  in  vitro  and  in  vivo.  Chitosan  was  used  as  a matrix  for the  formulation
of  a nanoemulsion.  Chromatographic  and  physico-chemical  analyses  of EcEO  were  per-
formed.  Egg  hatch  (EHT)  and  larval  development  (LDT)  tests  were  conducted  to  evaluate
the  effectiveness  of  nanoencapsulated  and free  EcEO  on  the eggs  and  larvae  of  Haemonchus
contortus.  Acute  toxicity  of free  and  nanoencapsulated  EcEO  was  evaluated  using  mice.
Finally,  nanoencapsulated  EcEO  efﬁcacy  on the  control  of  gastrointestinal  nematodes  was
calculated  by fecal  egg  count  reduction  test  (FECRT)  treating  30 sheep  naturally  infected
with 250  mg/kg  of  free  and  nanoencapsulated  EcEO.  In vitro  tests  were  analyzed  by an
analysis  of  variance  (ANOVA)  followed  by  comparison  with  the  Tukey  test.  The efﬁcacy
of FECRT  was  calculated  by the  BootStreet  program  through  arithmetic  average,  using the
formula  100  (1  − XT/XC).  To  compare  the  differences  between  epg,  the  data  were  trans-
formed  to log  (x + 1) and  subjected  to an ANOVA  to  compare  the  signiﬁcant  differences
between  groups  by  Tukey’s.  The  level of signiﬁcance  was P < 0.05.  The  free  (4  mg/ml  con-
centration)  and  nanoencapsulated  (2 mg/ml  concentration)  EcEO  inhibited  larvae  hatching
by  97.2%  and  92.8%,  respectively.  Free  and  nanoencapsulated  EcEO  at 8 mg/ml  inhibited
larval  development  by  99.8%  and  98.1%,  respectively.  In  the  acute  toxicity  test,  the LD10
and  LD50  of  free  EcEO  was  1999  and  2653  mg/kg,  respectively,  while  the LD10 and  LD50
of nanoencapsulated  EcEO was  1121  and  1681  mg/kg,  respectively.  Nanoencapsulated  and
free  EcEO  reduced  FEC  similarly  by  40.5%  and  55.9%,  respectively  at 10  days  post-treatment.
Nanoencapsulated  EcEO  did not  obtain  the  expected  efﬁcacy  in  vivo.
© 2014  Elsevier  B.V.  All  rights  reserved.
∗ Corresponding author at: Programa de Pós-graduac¸ ão em Ciências Veterinári
03  Fortaleza, Ceará, Brazil. Tel.: +55 85 31019853; fax: +55 85 31019840.
E-mail addresses: bevilaqua.uece@gmail.com, claudiamlb@yahoo.com.br, clau
http://dx.doi.org/10.1016/j.vetpar.2014.05.026
304-4017/© 2014 Elsevier B.V. All rights reserved.as/FAVET/UECE, Av. Silas Munguba, 1700, Campus do Itaperi, CEP 60714-
dia.bevilaqua@pq.cnpq.br (C.M.L. Bevilaqua).
y Parasit244 J.C. Ribeiro et al. / Veterinar
1. Introduction
Diseases caused by gastrointestinal nematodes in small
ruminants reduce animal production, causing serious eco-
nomic losses worldwide (Molento, 2009). In northeastern
Brazil, the following nematodes can be found in sheep: Tri-
chostrongylus spp., Oesophagostomum spp., Cooperia spp.,
Trichuris spp. and Haemonchus contortus, the latter is
an abomasal nematode that is prevalent throughout the
region (Melo et al., 2009). The inappropriate use of conven-
tional anthelmintics led to the emergence of drug-resistant
nematode populations (Jackson and Coop, 2000).
Currently, low cost and efﬁcient methods have been
studied to control and prevent infections with gastroin-
testinal parasites. Among these are pasture management,
selection of nematode resistant animals and the devel-
opment of herbal medicines with anthelmintic activity,
which involves the formulation of herbal drugs and
their metabolites (Vieira, 2008; Hoste and Torres-Acosta,
2011).
Eucalyptus spp., belonging to the family Myrtaceae, has
several species of economic importance, and its essen-
tial oils have been used for various purposes (Vitti and
Brito, 1999; Silva et al., 2006). The essential oil of Euca-
lyptus citriodora is well known for its use in the fragrance
industry, and its major constituent is citronellal (Vitti and
Brito, 2003). Studies have shown that E. citriodora oil func-
tions as an antioxidant (Singh et al., 2012), antifungal
(Brito et al., 2012), antibacterial (Cimanga et al., 2002)
anti-inﬂammatory, analgesic (Gbenou et al., 2013), insect
repellent (Seyoum et al., 2003), insecticide (Maciel et al.,
2010) and acaricide (Clemente et al., 2010).
Eucalyptus citriodora essential oil presented activity
against goat gastrointestinal nematodes, but the efﬁcacy
did not reach the therapeutically required level (Macedo
et al., 2011). Therefore, the encapsulation of essential
oils of E. citriodora was used to improve their efﬁcacy
against gastrointestinal nematodes of small ruminants
(Underwood and Eps, 2012). Encapsulation is the incor-
poration of a bioactive substance into a material called an
encapsulating matrix, coating material or carrier (Paramera
et al., 2011). This incorporation protects the drug from
degradation, improves its absorption and facilitates its dif-
fusion through the epithelium, thus promoting tissue and
intracellular distribution more efﬁciently (Couvreur and
Vauthier, 2006).
Chitosan is a natural polymer (Sahoo et al., 2010)
obtained by the deacetylation of chitin, the main compo-
nent of the exoskeleton of crustaceans and the cell wall
of some fungi (Sinha et al., 2004). It has been used as
an encapsulating matrix for drug delivery because it is
biodegradable, biocompatible, renewable, non-toxic and
aqueous, and it circumvents the need for organic sol-
vents (Senel et al., 2000; Abreu et al., 2012). The chitosan
microsphere formulation for the controlled release of drugs
improves their dissolution and bioavailability (Hejazi and
Amiji, 2003; Sinha et al., 2004). Thus, the aim of this
study was to evaluate the action of the essential oil of
E. citriodora on the gastrointestinal nematodes of small
ruminants by comparing both free and nanoencapsulated
forms.ology 204 (2014) 243–248
2. Materials and methods
This study was approved by the Ethics Committee for
the Use of Animals of State University of Ceará under pro-
tocol number 12641984-1 and followed the standards of
animal welfare recommended by law.
2.1. Chemical analysis of E. citriodora essential oil
Eucalyptus citriodora essential oil (EcEO) was  purchased
from FERQUIMA® (Vargem Grande Paulista, São Paulo,
Brazil). The chemical composition of the EcEO used in
this study was  determined by gas chromatography (GC)
and mass spectrometry (MS). The oil was  analyzed in
a Hewlett-Packard 5971 instrument using the following
experimental conditions: DB-1 coated fused silica capil-
lary column (30 m × 0.25 mm); helium carrier gas; injector
temperature of 250 ◦C; detector temperature of 200 ◦C; col-
umn  temperature program: 35–180 ◦C at 48 ◦C/min and
then 180–250 ◦C at 10 ◦C/min. For MS,  the electron impact
was  70 eV.
Compounds of EcEO were identiﬁed according to their
GC retention time expressed through Kovat’s index, which
was  calculated by the Van den Dool and Kratz equation
using a hydrocarbon homologous series (Adams, 2001).
Additionally, the test compound mass spectra were com-
pared to spectra in the National Institute for Standard
Technology computer database (NIST; 62,235 compounds)
and published spectra (Adams, 2001).
2.2. Nanoencapsulation of E. citriodora essential oil
Chitosan powder (POLYMAR®) was used as encapsu-
lant biopolymer. Chitosan was  solubilized in acetic acid
(1%) under constant stirring for 24 h to obtain a solution
of 1% chitosan. At the end of this period, vacuum ﬁltration
was  conducted for the remaining particles still in suspen-
sion. In parallel, Tween 80 was  added to EcEO at a ratio of
1:4 under constant stirring for 10 min. The organic phase
(EcEO + Tween 80) was  added to the 1% chitosan solution
under mechanical stirring for 5 min  at 188.49 rad seg−1,
thereby obtaining a nanoemulsion of chitosan. We tested
various proportions of the organic phase in relation to the
chitosan solution to obtain a stable product containing
higher oil content. The macroscopic characteristics of EcEO
stability were observed for 72 h after the preparation of the
nanoemulsion to monitor for a possible phase separation.
2.3. Physicochemical characterization of the
nanoemulsion
The nanoemulsion of EcEO was  characterized by
infrared spectroscopy (FTIR) using the model 8300
(Shimadzu Corporation, Japan). The particle size and
distribution were determined by photon correlation spec-
troscopy (PCS) on a Malvern Zetasizer Zen model 3500.2.4. Egg hatch test (EHT)
Feces were collected directly from the rectum of sheep
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nfection of H. contortus. H. contortus eggs were recov-
red according to Hubert and Kerboeuf (1992). The egg
atch test (EHT) was performed based on the method-
logy described by Coles et al. (2006). Brieﬂy, 250 ml
f an egg suspension, containing approximately 100
resh eggs, was incubated with 250 ml  of EcEO at con-
entrations of 4, 2, 1, 0.5, 0.25 and 0.125 mg/ml in
est tubes for 48 h at 25 ◦C. After this time, drops of
ugol iodine were added to the tubes. The eggs and
rst stage larvae (L1) were counted under a micro-
cope. Five groups were included: G1: nanoencapsulated
cEO; G2: free EcEO; G3: negative control containing 3%
ween 80 and 1% chitosan; G4: negative control con-
aining 3% Tween 80 and G5: positive control containing
.025 mg/ml  thiabendazole. Three repetitions with ﬁve
eplicates for each concentration and for each control were
erformed.
.5. Larval development test (LDT)
The larval development test (LDT) was performed using
n aliquot of egg suspension obtained as described by
ubert and Kerboeuf (1992). The suspension was  incu-
ated for 24 h at 37 ◦C to obtain L1. The LDT was performed
s described by Camurc¸ a-Vasconcelos et al. (2007). A 1 ml
liquot of solution containing approximately 250 L1 H.
ontortus was incubated with 2 g of feces collected from
 sheep free of gastrointestinal nematodes, and 1 ml  of
ils solution was added. After six days, third stage lar-
ae (L3) were recovered, and drops of Lugol were added.
he L3 were counted under an dissecting microscope. In
his test, ﬁve groups were included: G1: nanoencapsulated
cEO at concentrations of 8, 4, 2, 1 and 0.5 mg/ml; G2:
ree EcEO at the same concentrations; G3: negative control
onsisting of 3% Tween 80 and 1% chitosan; G4: negative
ontrol consisting of 3% Tween 80; G5: positive control
ith 0.008 mg/ml  ivermectin. Three repetitions with ﬁve
eplicates for each concentration and for each control were
erformed.
.6. Acute toxicity test
A total of 90 female Swiss albino mice (Mus  musculus)
ere used, and they weighed between 25.8 and 32.6 g. The
ice were kept in polypropylene cages and given commer-
ial feed and water ad libitum.  The animals were randomly
ivided into groups (n = 10) based on treatment: G1 to
4: 500, 1000, 1500 and 2000 mg/kg of nanoencapsulated
cEO, G5 to G8: 2000, 2500, 3000 and 3500 mg/kg of free
cEO and G9: 4000 mg/kg of matrix containing 1% chitosan
olution and 3% Tween 80.
A single dose of the oils and chitosan solution (con-
rol) were administered by esophageal gavage. The doses
ere established from the results of Macedo et al. (2011)
ssuming the nanoencapsulated oil could increase toxic-
ty. The animals were observed for 15 days, and behavioral
hanges and mortality were recorded. The total number of
ead animals was recorded to calculate the lethal dose for
0% (LD10) and 50% (LD50) of animals.ology 204 (2014) 243–248 245
2.7. Fecal egg count reduction test (FECRT)
A total of 30 crossbred sheep of both sexes was used,
and they weighed 30 kg on average and were aged between
6 and 18 months. The sheep lived in semi-intensive sys-
tems, were fed with commercial feed and hay and received
mineral salt and water ad libitum.
The sheep were selected according to the number of
eggs in feces (epg) over 500 using the McMaster technique
(Ueno and Gonc¸ alves, 1998). The sheep were divided into 3
groups (n = 10) and randomly assigned to treatment for FEC,
G1: 250 mg/kg of nanoencapsulated EcEO; G2: 250 mg/kg
of free EcEO; and G3: 250 mg/kg of 1% chitosan and 3%
Tween 80 (control). Feces were collected directly from the
rectum of the animals before and after 10 and 17 days of
treatment.
The dose was chosen based on the work of Macedo et al.
(2011) who used 500 mg/kg of free E. citriodora oil for 3
consecutive days and the results of the toxicity test with
nanoencapsulated oil.
Treatment efﬁcacy was  determined by the reduction of
epg, compared with control. Fecal cultures were performed
according to the method of Roberts and O’Sullivan for the
identiﬁcation of larvae.
2.8. Statistical analysis
The results of in vitro tests are presented as percentages
and were analyzed by an analysis of variance (ANOVA) fol-
lowed by comparison with the Tukey test using Graph Pad
Prism 5.0 software. The signiﬁcance level was  P < 0.05.
For EHT, the efﬁcacy of each treatment was  calculated
based on the percentage of hatching using the following
formula: (number of hatched larvae/number of hatched
larvae + number of eggs) × 100. For the LDT, the efﬁcacy of
each treatment was  calculated using the formula: [(L3 con-
trol group − L3 treated group)/L3 control group] × 100. The
effective concentration to inhibit 50% (EC50) of hatching
and larval development was  calculated by linear regres-
sion between the dose and efﬁcacy using probit analysis
with the SPSS 8.0 software.
The doses required to kill 50% (LD50) and 10% (DL10)
of mice were calculated from the acute toxicity by probit
analysis with the SPSS 8.0 software.
The efﬁcacy of FECRT was calculated by the BootStreet
program through arithmetic average, using the formula
100 (1 − XT/XC), where XT and XC are the average epg in
treatment and control groups, respectively (Coles et al.,
1992). The model used was  based on the pre-selection of
150 animals available in commercial farm. The ovines were
of both genders, with ages ranging from 6 to 18 months.
Opg of these animals was  done and 30 individuals with
opg above 500 were selected and distributed so that there
was no statistical difference between the opg of the groups
(n = 10). In this model, only opg and treatments were ana-
lyzed. To compare the differences between epg, the data
were transformed to log (x + 1) and subjected to an ANOVA
to compare the signiﬁcant differences between groups by
Tukey’s test using the Graph Pad Prism 5.0 software. The
signiﬁcance level was  P < 0.05.
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Fig. 2. Evaluation of acute toxicity of Eucalyptus citriodora free and
nanoencapsulated essential oil for mice.
Table 1
Efﬁcacy (±standard error) of the free and nanoencapsulated Eucalyptus
citriodora essential oil on hatching of eggs of Haemonchus contortus.
Concentrations (mg/ml) Efﬁcacy (%)
Free EcEO Nanoencapsulated EcEO
4 97.1 ± 0.2a –
2  58.5 ± 3.2b 92.8 ± 1.5a
1 23.5 ± 1.8c 85.5 ± 2.3b
0.5 16.0 ± 1.3d 56.8 ± 2.6c
0.25 12.5 ± 0.9de 25.9 ± 1.3d
0.125 – 11.9 ± 0.9e
Control 7.4 ± 0.7e 9.1 ± 0.5e
TBZ (0.025 mg/ml) 93.5 ± 1.1a 93.5 ± 1.1a
while those recovered 10 days after treatment were
Haemonchus spp. (90%), Trichostrongylus spp. (7%) and
Oesophagostumum spp. (3%).
Table 2
Efﬁcacy (±standard error) of the free and nanoencapsulated Eucalyptus
citriodora essential oil on L1 development of Haemonchus contortus.
Concentrations (mg/ml) Efﬁcacy (%)
Free EcEO Nanoencapsulated EcEO
8 99.7 ± 0.1Aa 98.0 ± 0.5Aa
4 83.8 ± 1.7Bb 75.8 ± 2.5Bb
2 47.5 ± 3.1Cc 49.4 ± 2.3Cc
1 25.1 ± 1.3Dd 39.1 ± 3.2Cc
0.5 14.4 ± 2.7Ee 10.0 ± 2.9De
Control 7.7 ± 2.5Ee 7.7 ± 1.6De
Aa AaFig. 1. Infrared spectra of the sample of Eucalyptus citriodora free essential
oil, chitosan (matrix) and nanoencapsulated E. citriodora essential oil.
3. Results
Chromatographic analysis revealed that the major EcEO
components were citronellal (67.5%), citronellol (6.9%) and
menthol (6.1%).
To obtain a stable nanoemulsion (no phase separa-
tion), 36.4% (v/v) of the EcEO content was used. Analysis
of the resulting nanoemulsion particles demonstrated a
mean size of 232 nm with unimodal distribution and poly-
dispersity. By infrared spectroscopy, chitosan displayed
absorption bands appearing at 1643, 1457, 1375 and
1099 cm−1 (Fig. 1). The characteristic absorption bands of
citronellal can be observed at 2923 and 1742 cm−1 and
are assigned to CH and C O aldehyde groups, respectively.
Vibrational modes of (CH) methyls and methylenes of the
essential oil components were observed between 3000 and
2800 cm−1. The absorption bands of the hydroxyl groups
(OH) of chitosan and the essential oil components was
observed between 3500 and 3340 cm−1.
In the acute toxicity test, the LD10 and LD50
of free EcEO were 1999.0 (1365.5–2286.1) mg/kg and
2653.0 (2337.9–2967.5) mg/kg, respectively, and the
LD10 and LD50 of nanoencapsulated EcEO was  1120.9
(551.7–1355.5) mg/kg and 1680.7 (1404.0–2269.4) mg/kg,
respectively (Fig. 2). In the acute toxicity test, no changes
were observed in the behavior of mice.
The inhibition of egg hatching was dose-dependent, and
the results are shown in Table 1. The dose of 4 mg/ml  of free
EcEO inhibited 97.2% of eggs hatching, while the nanoen-
capsulated EcEO inhibited 92.8% at a dose of 2 mg/ml. The
effective doses to inhibit 50% of hatching eggs (EC50) were
1.3 (0.5–8.7) and 0.4 (0.4–0.5) mg/ml  for free and nanoen-
capsulated EcEO, respectively.
The effectiveness of the larval development test was
also dose-dependent, and the results are shown in Table 2.
The most effective dose was 8 mg/ml  for both the free and
nanoencapsulated EcEO, which inhibited larval develop-
ment in 99.8% and 98.1% of cases, respectively. The EC50
for the development of larvae and 95% conﬁdence intervalsDifferent letters mean statistically different values (P < 0.05) in the same
column.
were 1.7 (1.0–2.6) and 1.7 (1.0–2.6) mg/ml  for free and
nanoencapsulated EcEO, respectively.
The FECRT of free and nanoencapsulated EcEO are
expressed as the mean epg on days 0, 10 and 17 post-
treatment (Table 3). Nanoencapsulated and free EcEO
reduced FEC by 40.5% and 55.9% at 10 days post-treatment,
but these results did not signiﬁcantly differ from the
control.
The larvae recovered in fecal cultures of sheep before
treatment were identiﬁed as Haemonchus spp. (94%), Tri-
chostrongylus spp. (5%) and Oesophagostumum spp. (1%),IVM (0.008 mg/ml) 98.9 ± 0.2 98.7 ± 0.2
Capital letters compare the means between the lines. Lowercase letters
compare the means between the columns. Results show different letters
differ signiﬁcantly (P < 0.05).
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Table  3
Reduction in egg counts per gram of feces (epg) and efﬁcacy of nanoen-
capsulated and free Eucalyptus citriodora essential oil (EcEO).
Treatments Day 0 Day 10 Day 17
Free EcEO
Mean epg 1920 ± 414.1Aa 915 ± 279.4Aab 615 ± 231.7Ab
Efﬁcacy (%) – 55.9 34.5
Nanoencapsulated EcEO
Mean epg 1930 ± 407.9Aa 1235 ± 282.2Aab 680 ± 174.5Ab
Efﬁcacy (%) – 40.5 27.6
Tween 80 (3%) + chitosan












































tapital letters compare the means between the lines. Lower case letters
ompare the means between the columns. Results show different letters
iffer signiﬁcantly (P < 0.05).
. Discussion
Anthelmintic resistance and the appreciation of organic
nimals have boosted the development of herbal medicines
ith anthelmintic activity, as this treatment is beneﬁcial
n small ruminant husbandry (Athanasiadou et al., 2007).
mong the studied products are essential oils, which are
olatile substances. The use of nanoemulsions is intended
o prevent oil degradation for oral administration, improv-
ng absorption in the animal body (Donsì et al., 2011).
his can lead to increased efﬁciency of the product with a
onsequent reduction in the frequency of treatment (Cui
t al., 2006). The process of nanoemulsion in this study
as satisfactory because the formulated particles ranged
rom 1–1000 nm (Irache et al., 2011). The percentage of
ncapsulation obtained was similar to other studies that
sed hydrogel formulations, which were obtained at a con-
entration of 36.5% (v/v) the EcEO (Mesquita et al., 2013;
ibeiro et al., 2013).
The use of chitosan as a matrix to encapsulate essential
ils or their compounds has been successful in several stud-
es using various encapsulation techniques (Keawchaoon
nd Yoksan, 2011). Chitosan has a positive charge, which
n turn draws lipids of a negative charge (Azevedo et al.,
007). Consequently, the compounds bind strongly. This
as the reason for the choice of chitosan as a matrix to
ncapsulate EcEO. Furthermore, the hydrophilic–lipophilic
alance of this substance is high, which allows it to stabilize
il–water emulsions (Schulz, 1998).
Infrared radiation causes atoms and groups of atoms
n organic compounds to vibrate with increased ampli-
ude around the covalent bonds that connect them. The
ibrational spectrum usually appears as a series of absorp-
ion bands. The positions of the absorption bands in
he spectrum can be displayed as a wave number using
everse drive centimeters (400–400 cm−1) or microme-
ers (2.5–16 m)  (Lopes and Fascio, 2004). The absorption
ands for chitosan and citronellal are characteristic of these
ompounds (Paula et al., 2011). However, the absorption
ands at 1565 cm−1, which corresponds to the group II
mide of chitosan, disappeared. This was most likely due to
 joining of the group II amide with the aldehyde citronellal
roups (Abreu et al., 2012), demonstrating encapsulation of
cEO by chitosan.
EcEO was also effective against gastrointestinal nema-
odes in vitro, inhibiting H. contortus egg hatching by 98.8%ology 204 (2014) 243–248 247
at a dose of 5.3 mg/ml  (Macedo et al., 2011). The results
from this study differed, as we  obtained a similar efﬁciency
using only 4 mg/ml  of free EcEO and 2 mg/ml  of nanoen-
capsulated EcEO. Although chitosan is insoluble in water,
organic solvents and bases (Damian et al., 2005), the prior
solubilization of chitosan in acetic acid in the present study
made it water-soluble, explaining the improved effective-
ness of the nanoencapsulated oil.
For the LDT, the results obtained with the free or
nanoencapsulated oil were statistically similar, however
free EcEO results were similar to Macedo et al. (2011). This
is likely due to the use of feces in the culture medium, which
hindered the solubility of chitosan and consequently, hin-
dered the effect on the larvae.
Previous studies have shown that the LD10 and LD50,
conducted through acute toxicity tests of EcEO, were 2609
(689.7–3466.4) mg/kg and 4153.2 (2861.8–5849.2) mg/kg,
respectively (Macedo et al., 2011). These results do not
corroborate the current study because the lethal doses
were lower for the free and nanoencapsulated EcEO. Fur-
thermore, the nanoencapsuled oil toxicity increased, but
chitosan is not known to be toxic, so this process probably
resulted in increased oil toxicity.
The effectiveness of EcEO at 500 mg/kg over three con-
secutive days in goats was  66.2% and 60.3% at 8 and 15
days post-treatment, respectively (Macedo et al., 2011). In
the present study, we observed increased efﬁcacy of free
and nanoencapsulated oil, as similar results were obtained
with only a single dose of 250 mg/kg. Nevertheless, the
FEC did not differ statistically between the control and the
treatments. This may  be because the test was performed
at the beginning of the dry season in the semi-arid region
of northeastern Brazil. At this time, the epg and worm bur-
dens suffer drastic reductions because the free-living stages
cannot survive on pasture (Arosemena et al., 1999).
Since one of the properties of chitosan is mucoadhe-
sivity, we  expected that the nanoencapsulated oil with
chitosan would extend the residence time in the aboma-
sum, thus optimizing the effect. However as the results of
the nanoencapsulated oil were not higher than the free oil,
yet clariﬁcations about the oil release mechanism in abo-
masal pH are needed (Ribeiro et al., 2013). However, the
use of this oil for the control of gastrointestinal nematodes
in small ruminants should not be disregarded because it is
possible to develop other encapsulating matrices that are
more efﬁcient than chitosan. Thus, plant products can be
an alternative for the control of these parasites and may  be
used in combination with synthetic products to enhance
their effectiveness.
Conﬂict of interest
The authors declare that they have no conﬂicting
interests.
AcknowledgementsThe work received ﬁnancial support from PRODOC/
CAPES (503908/2012-6) and PDJ/CNPq (503908/2012-
6). CAPES (AUX-PE-PRODOC 2717/2010) and CNPq (PDJ
y Parasit248 J.C. Ribeiro et al. / Veterinar
503908/2012-6). Dr. Bevilaqua, Dr. Macedo and Dr.
Camurc¸ a-Vasconcelos have grants from CNPq and CAPES.
References
Abreu, F.O.M.S., Oliveira, E.F., Paula, H.C.B., De Paula, R.C.M., 2012.
Chitosan/cashew gum nanogels for essential oil encapsulation. Car-
bohydr. Polym. 89, 1277–1282.
Adams, R.P., 2001. Identiﬁcation of Essential Oil Components by Gas Chro-
matography/Quadrupole Mass Spectroscopy, 4 ed. Allured, Illinois,
456 pp.
Arosemena, N.A.E., Bevilaqua, C.M.L., Melo, A.C.F.L., Girão, M.D., 1999. Sea-
sonal variations of gastrointestinal nematodes in sheep and goats from
semi-arid areas in Brazil. Rev. Méd. Vét. 150, 873–876.
Athanasiadou, S., Githiori, J., Kyriazakis, I., 2007. Medicinal plants for
helminth parasite control: facts and ﬁction. Animal 1, 1392–1400.
Azevedo, V.V.C., Chaves, S.A., Bezerra, D.C., Fook, M.V.L., Costa, A.C.F.M.,
2007. Quitina e Quitosana: aplicac¸ ões como biomateriais. Rev. Eletrôn.
Mater. Process. 2.3, 27–34.
Brito, D.R., Ootani, M.A., Ramos, A.C.C., Sertão, W.C., Aguiar, R.W.S., 2012.
Efeito dos óleos de citronela, eucalipto e composto citronelal sobre
micoﬂora e desenvolvimento de plantas de milho. J. Biotec. Biodivers.
3, 184–192.
Camurc¸ a-Vasconcelos, A.L.F., Bevilaqua, C.M.L., Morais, S.M., Maciel, M.V.,
Costa, C.T.C., Macedo, I.T.F., Oliveira, L.M.B., Braga, R.R., Silva, R.A.,
Vieira, L.S., 2007. Anthelmintic activity of Croton zehntneri and Lippia
sidoides essential oils. Vet. Parasitol. 148, 288–294.
Cimanga, K., Kambu, K., Tona, L., Apers, S., De Bruyne, T., Hermans, N.,
Totté, J., Pieters, L., Vlietinck, A.J., 2002. Correlation between chemical
composition and antibacterial activity of essential oils of some aro-
matic medicinal plants growing in the Democratic Republic of Congo.
J.  Ethnopharmacol. 79, 213–220.
Clemente, M.A., Monteiro, C.M.O., Scoralik, M.G., Gomes, F.T., Prata, M.C.A.,
Daemon, E., 2010. Acaricidal activity of the essential oils from Euca-
lyptus citriodora and Cymbopogon nardus on larvae of Amblyomma
cajennense (Acari: Ixodidae) and Anocentor nitens (Acari: Ixodidae).
Parasitol. Res. 107, 987–992.
Coles, G.C., Bauer, C., Borgsteede, F.H.M., Geerts, S., Klei, T.R., Taylor,
M.A., Waller, P.J., 1992. World Association for the Advancement of
Veterinary Parasitology (W.A.A.V.P.) methods for the detection of
anthelmintic resistance in nematodes of veterinary importance. Vet.
Parasitol. 44, 35–44.
Coles, G.C., Jackson, F., Pomroy, W.E., Prichard, R.K., Von Samson-
Himmelstjerna, G., Silvestre, A., Taylor, M.A., Vercruysse, J., 2006.
The detection of anthelmintic resistance in nematodes of veterinary
importance. Vet. Parasitol. 136, 167–185.
Couvreur, P., Vauthier, C., 2006. Nanotechnology: intelligent design to
treat complex disease. Pharm. Res. 23, 1417–1450.
Cui, J.Y.F., Han, X., Wang, Y.S., Yang, L., Yu, Y.W., Li, Q.P., 2006. Study of the
preparation of sustained-release microspheres containing zedoary
turmeric oil by the emulsion–solvent-diffusion method and evalua-
tion of the self-emulsiﬁcation and bioavailability of the oil. Colloids
Surf. B. 48, 35–41.
Damian, C., Beirão, L.H., Francisco, A., Espírito Santo, M.L.P., Teixeira, E.,
2005. Quitosana: Um amino polissacarídio com características fun-
cionais. Alim. Nutr. 16, 195–205.
Donsì, F., Annunziata, M.,  Sessa, M.,  Ferrari, G., 2011. Nanoencapsulation
of essential oils to enhance their antimicrobial activity in foods. Food.
Sci.  Technol. 44, 1908–1914.
Gbenou, J.D., Ahounou, J.F., Akakpo, H.B., Laleye, A., Yayi, E., Gbaguidi, F.,
Baba-Moussa, L., Darboux, R., Dansou, P., Moudachirou, M.,  Kotchoni,
S.O., 2013. Phytochemical composition of Cymbopogon citratus and
Eucalyptus citriodora essential oils and their anti-inﬂammatory and
analgesic properties on Wistar rats. Mol. Biol. Rep. 40, 1127–1134.
Hejazi, R., Amiji, M.,  2003. Chitosan-based gastrointestinal delivery sys-
tems. J. Control. Release 89, 151–165.
Hoste, H., Torres-Acosta, J.F.J., 2011. Non chemical control of helminths
in ruminants: adapting solutions for changing worms in a changing
world. Vet. Parasitol. 180, 144–154.
Hubert, J., Kerboeuf, D., 1992. A microlarval development assay for the
detection of anthelmintic resistance in sheep nematodes. Vet. Rec.
151, 442–446.ology 204 (2014) 243–248
Irache, J.M., Esparza, I., Gamazo, C., Agüeros, M.,  Espuelas, S., 2011.
Nanomedicine: novel approaches in human and veterinary therapeu-
tics.  Vet. Parasitol. 180, 47–71.
Jackson, F., Coop, R.L., 2000. The development of anthelmintic resistance
in  sheep nematodes. Parasitology 120, 95–107.
Keawchaoon, L., Yoksan, R., 2011. Preparation, characterization and in vitro
release study of carvacrol-loaded chitosan nanoparticles. Colloids
Surf. B.84, 163–171.
Lopes, W.A., Fascio, M.,  2004. Esquema para interpretac¸ ão de espectros
de substâncias orgânicas na região do infravermelho. Quim. Nova. 27,
670–673.
Macedo, I.T.F., Bevilaqua, C.M.L., Oliveira, L.M.B., Camurc¸ a-Vasconcelos,
A.L.F., Vieira, L.S., Amóra, S.S.A., 2011. Evaluation of Eucalyptus cit-
riodora essential oil on goat gastrointestinal nematodes. Rev. Bras.
Parasitol. Vet. 20, 223–227.
Maciel, M.V., Morais, S.M., Bevilaqua, C.M.L., Silva, R.A., Barros, R.S., Sousa,
L.C.,  Brito, E.S., Souza-Neto, M.A., 2010. Chemical composition of Euca-
lyptus spp. essential oils and their insecticidal effects on Lutzomyia
longipalpis.  Vet. Parasitol. 167, 1–7.
Melo, A.C.F.L., Bevilaqua, C.M.L., Reis, I.F., 2009. Resistência aos
anti-helmínticos benzimidazóis em nematóides gastrintestinais de
pequenos ruminantes do Semiárido nordestino brasileiro. Ci. An. Bras.
10,  294–300.
Mesquita, M.A., Silva Júnior, J.B., Panassol, A.M., Oliveira, E.F., Camurc¸ a-
Vasconcelos, A.L.F., de Paula, H.C.B., Bevilaqua, C.M.L., 2013.
Anthelmintic activity of Eucalyptus staigeriana encapsulated oil on
sheep gastrointestinal nematodes. Parasitol. Res. 112, 3161–3165.
Molento, M.B., 2009. Parasite control in the age of drug resistance and
changing agricultural practices. Vet. Parasitol. 163, 229–234.
Paramera, E.I., Konteles, S.J., Karathanos, V.T., 2011. Stability and release
properties of curcumin encapsulated in Saccharomyces cerevisiae, -
cyclodextrin and modiﬁed starch. Food Chem. 125, 913–922.
Paula, H.C.B., Sombra, F.M., Cavalcante, R.F., Abreu, F.O.M.S., Paula, R.C.M.,
2011. Preparation and characterization of chitosan/cashew gum beads
loaded with Lippia sidoides essential oil. Mater. Sci. Eng. C 31, 173–178.
Ribeiro, W.L.C., Macedo, I.T.F., Santos, J.M.L., Oliveira, E.F., Camurc¸ a-
Vasconcelos, A.L.F., de Paula, H.C.B., Bevilaqua, C.M.L., 2013. Activity
of chitosan-encapsulated Eucalyptus staigeriana essential oil on
Haemonchus contortus. Exp. Parasitol. 135, 24–29.
Sahoo, S., Sasmal, A., Nanda, R., Phani, A.R., Nayak, P.L., 2010. Synthesis
of  chitosan–polycaprolactone blend for control delivery of oﬂoxacin
drug. Carbohydr. Polym. 79, 106–113.
Schulz, P.C., 1998. Emulsiﬁcation properties of chitosan. Colloid Polym.
Sci. 276, 1159–1165.
Senel, S., Kremer, M.J., Kas, S., Wertz, P.W., Hmncal, A.A., Squier, C.A., 2000.
Enhancing effect of chitosan on peptide drug delivery across buccal
mucosa. Biomaterials 21, 2067–2071.
Seyoum, A., Killeen, G.F., Kabiru, E.W., Knols, B.G.J., Hassanali, A., 2003.
Field efﬁcacy of thermally expelled or live potted repellent plants
against African malaria vectors in western Kenya. Trop. Med. Int.
Health 8, 1005–1011.
Silva, P.H.M., Brito, J.O., Silva Junior, F.G., 2006. Potential of eleven euca-
lyptus species for the production of essential oils. Sci. Agric. 63, 85–89.
Singh, H.P., Kaur, S., Negi, K., Kumari, S., Saini, V., Batish, D.R., Kohli, R.K.,
2012. Assessment of in vitro antioxidant activity of essential oil of
Eucalyptus citriodora (lemon-scented Eucalypt; Myrtaceae) and its
major constituents. Food Sci. Technol. 48, 237–241.
Sinha, V.R., Singla, A.K., Wadhawan, S., Kaushik, R., Kumria, R., Bansal, K.,
Dhawan, S., 2004. Chitosan microspheres as a potential carrier for
drugs. Int. J. Pharm. 274, 1–33.
Ueno, H., Gonc¸ alves, P.C., 1998. Manual para diagnóstico das helmintoses
de  ruminantes, 4th ed. Japan International Cooperation Agency,
Tokyo, Japan, pp. 143.
Underwood, C., Eps, A.W.V., 2012. Nanomedicine and veterinary science:
the reality and the practicality. Vet. J. 193, 12–23.
Vieira, L.S., 2008. Métodos alternativos de controle de namatoides gastrin-
testinais em caprinos e ovinos. Rer. Tecnol. Ciên. Agropec. 2, 49–56.
Vitti, A.M.S., Brito, J.O., 2003. Óleo essencial de eucalipto (Documentos
ﬂorestais). Escola superior de agricultura “Luiz de Queiroz” da Uni-
versidade de São Paulo, pp. 17.
Vitti, A.M.S., Brito, J.O., 1999. Avaliac¸ ão do rendimento e do teor de cit-
ronelal do óleo essencial de procedências e rac¸ as locais de Eucalyptus
citriodora. Sci. For. 56, 145–154.
